2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Heart Decompensation: new trials by email Literature Review of Heart Decompensation trials Research Report on Heart Decompensation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic BMS-986231, Furosemide, Placebo - Cardiac Failure, Myocardial Failure | Phase 2 | Completed | Bristol-Myers Squibb | 23 | 2019-01-17 | 2021-02-26 |
| Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure Carperitide, Placebo - Heart Failure, Congestive, Heart Decompensation | Phase 2 | Completed | Daiichi Sankyo | 162 | 2004-01-01 | 2016-11-08 |
Heart Failure (2) · Cardiomyopathies (1) · Systolic Murmurs (1) · Ventricular Dysfunction, Left (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Heart Murmurs (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Ventricular Dysfunction (1)
Furosemide (1) · NPPA protein, human (1)
Bristol-Myers Squibb (1) · Daiichi Sankyo (1)
Canada (1) · United Kingdom (1) · United States (1)
Biljana Pavlovic-Surjancev, MD, PhD (1)
2018 (1)